282 related articles for article (PubMed ID: 31039142)
1. Butyrophilin-Like 9 (BTNL9) Suppresses Invasion and Correlates with Favorable Prognosis of Uveal Melanoma.
Jiang Z; Liu F
Med Sci Monit; 2019 Apr; 25():3190-3198. PubMed ID: 31039142
[TBL] [Abstract][Full Text] [Related]
2. miR-224-5p inhibits proliferation, migration, and invasion by targeting PIK3R3/AKT3 in uveal melanoma.
Li J; Liu X; Li C; Wang W
J Cell Biochem; 2019 Aug; 120(8):12412-12421. PubMed ID: 30825222
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the Expression and Single-Nucleotide Variant Frequencies of the Butyrophilin-like 2 Gene in Patients With Uveal Melanoma.
Amaro A; Parodi F; Diedrich K; Angelini G; Götz C; Viaggi S; Maric I; Coviello D; Pistillo MP; Morabito A; Mandalà M; Ghiorzo P; Visconti P; Gualco M; Anselmi L; Puzone R; Lanza F; Mosci C; Raggi F; Bosco MC; Varesio L; Zeschnigk M; Spano L; Queirolo P; Pfeffer U
JAMA Ophthalmol; 2016 Oct; 134(10):1125-1133. PubMed ID: 27532663
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of BCL2 19 kD Protein-Interacting Protein 3 (BNIP3) is Predictive of Unfavorable Prognosis in Uveal Melanoma.
Jiang Z; Yu F; Li M
Med Sci Monit; 2018 Jul; 24():4711-4717. PubMed ID: 29982263
[TBL] [Abstract][Full Text] [Related]
5. HIC1 modulates uveal melanoma progression by activating lncRNA-numb.
Cheng G; He J; Zhang L; Ge S; Zhang H; Fan X
Tumour Biol; 2016 Sep; 37(9):12779-12789. PubMed ID: 27449031
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of legumain in uveal melanoma.
Wu T; Sun L; Wu Y; Xiang R; Li Y; Rong W; Sun F; Wang N
Mol Med Rep; 2016 Mar; 13(3):2377-84. PubMed ID: 26846877
[TBL] [Abstract][Full Text] [Related]
7. Grb2-associated binder 2 expression and its roles in uveal melanoma invasion.
Chen M; Li Y; Sun X; Zhang B; Li W; Wang S; Zhu X; Li F; Shi L
Mol Med Rep; 2017 Oct; 16(4):4577-4582. PubMed ID: 28791340
[TBL] [Abstract][Full Text] [Related]
8. Expression of nm23-H1 in uveal melanoma.
Bakalian S; Marshall JC; Faingold D; Logan P; Antecka E; Burnier MN
Melanoma Res; 2007 Oct; 17(5):284-90. PubMed ID: 17885583
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of son of sevenless homolog 1 is predictive of poor prognosis in uveal malignant melanoma patients.
Wang YS; Wu L
Ophthalmic Genet; 2019 Feb; 40(1):22-28. PubMed ID: 30714452
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
[TBL] [Abstract][Full Text] [Related]
11. Expression of the serotonin receptor 2B in uveal melanoma and effects of an antagonist on cell lines.
Weidmann C; Bérubé J; Piquet L; de la Fouchardière A; Landreville S
Clin Exp Metastasis; 2018 Mar; 35(3):123-134. PubMed ID: 29696577
[TBL] [Abstract][Full Text] [Related]
12. AHNAK Nucleoprotein 2 Performs a Promoting Role in the Proliferation and Migration of Uveal Melanoma Cells.
Li M; Liu Y; Meng Y; Zhu Y
Cancer Biother Radiopharm; 2019 Dec; 34(10):626-633. PubMed ID: 31621397
[TBL] [Abstract][Full Text] [Related]
13. LncRNA PVT1 knockdown affects proliferation and apoptosis of uveal melanoma cells by inhibiting EZH2.
Huang XM; Shi SS; Jian TM; Tang DR; Wu T; Sun FY
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2880-2887. PubMed ID: 31002139
[TBL] [Abstract][Full Text] [Related]
14. Verification of EZH2 as a druggable target in metastatic uveal melanoma.
Jin B; Zhang P; Zou H; Ye H; Wang Y; Zhang J; Yang H; Pan J
Mol Cancer; 2020 Mar; 19(1):52. PubMed ID: 32127003
[TBL] [Abstract][Full Text] [Related]
15. Constitutive expression of c-REL in uveal melanoma patients: correlation with clinicopathological parameters and patient outcome.
Singh MK; Singh L; Pushker N; Chosdol K; Bakhshi S; Meel R; Sen S; Kashyap S
Clin Transl Oncol; 2020 Jul; 22(7):1193-1204. PubMed ID: 31768922
[TBL] [Abstract][Full Text] [Related]
16. The role of RASSF1A in uveal melanoma.
Dratviman-Storobinsky O; Cohen Y; Frenkel S; Merhavi-Shoham E; El SD; Binkovsky N; Pe'er J; Goldenberg-Cohen N
Invest Ophthalmol Vis Sci; 2012 Oct; 53(6):2611-9. PubMed ID: 22447862
[TBL] [Abstract][Full Text] [Related]
17. BTNL9 is frequently downregulated and inhibits proliferation and metastasis via the P53/CDC25C and P53/GADD45 pathways in breast cancer.
Mo Q; Xu K; Luo C; Zhang Q; Wang L; Ren G
Biochem Biophys Res Commun; 2021 May; 553():17-24. PubMed ID: 33756341
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of thrombospondin 2 inhibits metastasis through modulation of PI3K signaling pathway in uveal melanoma cell line M23.
Liu QH; Ma LS
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6230-6238. PubMed ID: 30338785
[TBL] [Abstract][Full Text] [Related]
19. CD166high Uveal Melanoma Cells Represent a Subpopulation With Enhanced Migratory Capacity.
Djirackor L; Kalirai H; Coupland SE; Petrovski G
Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2696-2704. PubMed ID: 31242292
[TBL] [Abstract][Full Text] [Related]
20. P2RX7-V3 is a novel oncogene that promotes tumorigenesis in uveal melanoma.
Pan H; Ni H; Zhang L; Xing Y; Fan J; Li P; Li T; Jia R; Ge S; Zhang H; Fan X
Tumour Biol; 2016 Oct; 37(10):13533-13543. PubMed ID: 27468714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
